Maternal & Child Health Research Institute (MCHRI)
Showing 1,001-1,020 of 1,222 Results
-
Sean Paul Spencer, MD,PhD
Assistant Professor of Medicine (Gastroenterology and Hepatology)
BioSean Spencer, MD,PhD is a Gastroenterologist and Physician Scientist at Stanford University working to uncover the role of dietary intake on the gut microbiome and mucosal immune system. Sean obtained his medical degree University of Pennsylvania, earning his PhD studying nutritional immunology with Yasmine Belkaid,PhD at the National Institutes of Health (NIH), after which he moved to Boston for residency training at Massachusetts General Hospital and completed his Gastroenterology training at Stanford University. Sean’s career goal is to study mechanisms by which dietary intake influences our microbiome and immune system to better understand and treat gastrointestinal disease. Sean has launched a microbiome-focused clinical practice at Stanford where he is working to develop novel microbiome diagnostics and microbial medicines.
-
Edda Spiekerkoetter
Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsPulmonary Arterial Hypertension
Pulmonary Vascular Remodeling
Modulation of BMPR, ENG, ACVRL1 (ALK1), SMAD signaling
Structural and molecular programs governing right ventricular adaptation and failure
Hereditary Hemorrhagic Telangiectasia
Pulmonary Arteriovenous malformations
Computational Drug Prediction and Repurposing
Deep Tissue Confocal Imaging -
Daniel Spielman
Professor of Radiology (Radiological Sciences Lab) and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsMy research interests are in the field of medical imaging, particularly magnetic resonance imaging and in vivo spectroscopy. Current projects include MRI and MRS at high magnetic fields and metabolic imaging using hyperpolarized 13C-labeled MRS.
-
Joshua M. Spin
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsDr. Spin began his research career studying the structural biology of low density lipoprotein, and has had intensive training in molecular biology techniques, particularly high-throughput genetic expression profiling. He is especially interested in vascular smooth muscle cells, and the role of smooth muscle differentiation and phenotypic switching in development, and in vascular disease. His latest work has focused on the biology of aortic aneurysms.
-
Chelse Spinner, PhD, MPH
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioAn Ohio native, Dr. Chelse Spinner obtained a Bachelor of Science in Biological Sciences (Biomedical Studies) with a minor in Health Education from the University of Cincinnati. She earned a Master of Public Health in Epidemiology and Maternal & Child Health (MCH) from the University of South Florida. She received a Doctor of Philosophy in Public Health Sciences with a concentration in Behavioral Sciences from the University of North Carolina at Charlotte. Dr. Spinner is certified in public health and has experience working across health systems. Her research interests include health disparities, women’s health, social determinants of health, domains of structural racism, and oral-systemic health within the MCH population. She employs quantitative and qualitative methods in the hopes of providing innovative and evidence-informed research to improve health outcomes for marginalized and underserved communities. Her research agenda intends to focus on the exploration of social and structural factors that impact health and well-being.
-
Alfred M. Spormann
Professor of Civil and Environmental Engineering and of Chemical Engineering, Emeritus
Current Research and Scholarly InterestsMetabolism of anaerobic microbes in diseases, bioenergy, and bioremediation
-
James Spudich
Douglass M. and Nola Leishman Professor of Cardiovascular Disease, Emeritus
Current Research and Scholarly InterestsThe general research interest of this laboratory is the molecular basis of cell motility, with a current emphasis on power output by the human heart. We have three specific research interests, the molecular basis of energy transduction that leads to ATP-driven myosin movement on actin, the biochemical basis of the regulation of actin and myosin interaction and their assembly states, and the roles these proteins play in vivo, in cell movement, changes in cell shape and muscle contraction.
-
Gayathri Srinivasan OD, MS
Clinical Associate Professor, Ophthalmology
BioDr. Srinivasan is a Clinical Associate Professor in the Department of Ophthalmology at Stanford University. Her clinical focus is on the management of amblyopia, strabismus, childhood refractive errors, and concussion-related vision disorders in children and adults. Dr. Srinivasan's research interests are amblyopia, strabismus, and concussion-related vision disorders. She serves as co-Investigator in ongoing clinical trials through the Pediatric Eye Disease Investigator Group (PEDIG), funded by the NIH, and chairs the Pediatrics and Strabismus subgroup within the Observational Health Data Sciences and Informatics (OHDSI) network.
-
Randall Stafford
Professor of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsAs Director of the SPRC Program on Prevention Outcomes and Practices, my work focuses on cardiovascular disease treatment and prevention, the adoption of new technology and practices, and patterns of physician practice, particularly medication prescribing. Specific interests include measuring and improving the quality of outpatient care, disparities in health care by race, gender, age and socioeconomic status, and interventions to improve prevention outcomes.
-
Marcia L. Stefanick, Ph.D.
Professor (Research) of Medicine (Stanford Prevention Research Center), of Obstetrics and Gynecology and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMarcia L. Stefanick, Ph.D is a Professor of Medicine Professor of Obstetrics and Gynecology, and by courtesy, Professor of Epidemiology and Population Health at Stanford University School of Medicine. Dr. Stefanick’s research focuses on chronic disease prevention (particularly, heart disease, breast cancer, osteoporosis, and dementia) in both women and men. She is currently the Principal Investigator the Women’s Health Initiative (WHI) Extension Study, having been the PI of the Stanford Clinical Center of the landmark WHI Clinical Trials and Observational Study since 1994 and Chair of the WHI Steering and Executive Committees from 1998-2011, as well as PI of the WHI Strong and Healthy (WHISH) Trial which is testing the hypothesis that a DHHS-based physical activity intervention, being delivered to a multi-ethnic cohort of about 24,000 WHI participants across the U.S., aged 68-99 when the trial started in 2015, will reduce major cardiovascular events over 8 years, compared to an equal number of “usual activity” controls. Dr. Stefanick is also PI of the Osteoporotic Study of Men (MrOS) which is continuing to conduct clinical assessments of bone and body composition in survivors of an original cohort of nearly 6000 men aged 65 and over in 2001. As founding Director of the Stanford Women’s Health and Sex Differences in Medicine (WHSDM, “wisdom”) Center, she plays a major role in promoting research and teaching on Sex and Gender in Human Physiology and Disease, Women’s Health and Queer Health and Medicine. Dr. Stefanick also plays major leadership roles at the Stanford School of Medicine, including as co-leader of the Population Sciences Program of the Stanford Cancer Institute, Stanford’s NCI-funded comprehensive cancer center.
Dr. Stefanick obtained her B.A. in biology from the University of Pennsylvania, Philadelphia, PA (1974), then pursued her interest in hormone and sex difference research at the Oregon Regional Primate Research Center, after which she obtained her PhD in Physiology at Stanford University, focusing on reproductive physiology and neuroendocrinology, with exercise physiology as a secondary focus. Her commitment to human research led to a post-doctoral fellowship in Cardiovascular Disease Prevention at the Stanford Prevention Research Center, which has been her academic home for nearly 40 years. -
Katherine Steffen
Clinical Professor, Pediatrics - Critical Care
Current Research and Scholarly InterestsMy research interests focus on using dissemination and implementation science tools to study and enhance care provided to patients in the pediatric ICU. I have a background in human factors research and in implementation science and am also interested in clinical effectiveness and outcomes in the PICU.
-
Lea Steffes
Assistant Professor of Pediatrics (Pulmonary Medicine)
BioDr. Steffes is a pediatric pulmonologist and Assistant Professor in Pediatrics in the Division of Pulmonary Medicine at Stanford University. She has completed an advanced fellowship in Pulmonary Vascular Disease at Lucile Packard Children's Hospital Stanford. Her clinical expertise focuses on rare pediatric lung diseases, with particular specialization in heritable forms of pulmonary vascular disease and developmental lung disorders.
Dr. Steffes' research centers on understanding the cellular characteristics of occlusive neointimal lesions, the abnormal cells that obstruct pulmonary blood flow in pulmonary hypertension. Her work specifically examines the contribution of mesenchymal cell subsets to pediatric pulmonary vascular disease, delineating mechanisms within both pre- and post-capillary networks. By leveraging insights from developing human and diseased mouse lung, her research provides a mechanistic framework for understanding childhood-onset pulmonary vascular diseases with the ultimate goal of identifying novel therapeutic targets for pulmonary hypertension. -
Lawrence Steinman, MD
George A. Zimmermann Professor and Professor of Pediatrics
Current Research and Scholarly InterestsOur laboratory is dedicated to understanding the pathogenesis of autoimmune diseases, particularly multiple sclerosis. We have developed several new therapies for autoimmunity, including some in Phase 2 clinical trials, as well as one approved drug, natalizumab. We have developed microarray technology for detecting autoantibodies to myelin proteins and lipids. We employ a diverse range of molecular and celluar approaches to trying to understand multiple sclerosis.
-
Lars Steinmetz
Dieter Schwarz Foundation Endowed Professor
Current Research and Scholarly InterestsThe Steinmetz lab develops genomic technologies to study the genetic basis of complex phenotypes, the mechanisms of gene regulation, and the molecular systems underpinning disease. We’re leveraging biological insights across scales and organisms to predict, diagnose, treat and ultimately prevent disease.
